Week 24+ Maximum clinical efficacy
In the obese trial cohort, 1 mg moved 24-hour ambulatory heart rate by +0.7 bpm at week 24 the peak of the heart-rate curve, and below the placebo arms +0.8. In a healthy lean Phase 1 group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
What To Expect From AOD Peptide Therapy What can you expect from AOD peptide therapy
High fever with chill Increasing redness, warmth, swelling, or pain at the injection site A pus-like discharge Red streaks spreading outward from the injection site Common Reasons for Needing an IM Injection Self-administered IM injections may be used for different reasons, including assisted fertility treatments, gender-affirming hormone therapy, vitamin B12 supplementation, and some disease-modifying treatments for autoimmune diseases like rheumatoid arthritis
Research Applications This product has been studied in various research contexts
Aftercare To support a smooth experience following your vitamin injection: Stay hydrated and plan for light activity for the remainder of the day